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State-of-the-art monitoring in treatment of
dengue shock syndrome: a case series
Steven L. Moulton1,2, Jane Mulligan2, Anon Srikiatkhachorn3, Siripen Kalayanarooj4, Greg Z. Grudic2,
Sharone Green3, Robert V. Gibbons5,6, Gary W. Muniz6, Carmen Hinojosa-Laborde6, Alan L. Rothman7,
Stephen J. Thomas5,8 and Victor A. Convertino6*
Abstract
Background: Early recognition and treatment of circulatory volume loss is essential in the clinical management of
dengue viral infection. We hypothesized that a novel computational algorithm, originally developed for noninvasive
monitoring of blood loss in combat casualties, could: (1) indicate the central volume status of children with dengue
during the early stages of “shock”; and (2) track fluid resuscitation status.
Methods: Continuous noninvasive photoplethysmographic waveforms were collected over a 5-month period from
three children of Thai ethnicity with clinical suspicion of dengue. Waveform data were processed by the algorithm
to calculate each child’s Compensatory Reserve Index, where 1 represents supine normovolemia and 0 represents
the circulatory volume at which hemodynamic decompensation occurs. Values between 1 and 0 indicate the
proportion of reserve remaining before hemodynamic decompensation.
Results: This case report describes a 7-year-old Thai boy, another 7-year-old Thai boy, and a 9-year-old Thai boy
who exhibited signs and symptoms of dengue shock syndrome; all the children had secondary dengue virus
infections, documented by serology and reverse transcriptase polymerase chain reaction. The three boys
experienced substantial plasma leakage demonstrated by pleural effusion index >25, ascites, and >20 %
hemoconcentration. They received fluid administered intravenously; one received a blood transfusion. All three
boys showed a significantly low initial Compensatory Reserve Index (≥0.20), indicating a clinical diagnosis of “near
shock”. Following 5 days with fluid resuscitation treatment, their Compensatory Reserve Index increased towards
“normovolemia” (that is, Compensatory Reserve Index >0.75).
Conclusions: The results from these cases demonstrate a new variation in the diagnostic capability to manage
patients with dengue shock syndrome. The findings shed new light on a method that can avoid possible adverse
effects of shock by noninvasive measurement of a patient’s compensatory reserve rather than standard vital signs
or invasive diagnostic methods.
Keywords: Machine learning, Decision support, Pulse oximetry, Dengue shock syndrome
Background
Nearly 400 million people are infected with dengue virus
(DENV) every year, making dengue the most common
mosquito-borne viral disease in humans [1]. The clinical
manifestations of DENV infection range from an asymp-
tomatic infection to a debilitating but self-limited illness
termed dengue fever (DF), to more severe forms of the
disease characterized by increased vascular permeability
and plasma leakage, known as dengue hemorrhagic fever
(DHF) and dengue shock syndrome (DSS) [2, 3].
Approximately 5 to 10 % of dengue patients experience
DHF [3]. The characteristic signs and symptoms of DHF
may include abdominal pain, persistent vomiting, pe-
techiae, epistaxis, gingival and gastrointestinal bleeding,
microscopic hematuria, thrombocytopenia and, most
importantly, hemoconcentration due to increased vascu-
lar permeability and third space fluid losses into the
pleural and peritoneal cavities. Patients with DHF may
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progress to develop DSS, evidenced by signs of circula-
tory failure, including tachycardia, a narrow pulse pres-
sure, hypotension and, in its late stages, lethargy and
other mental status changes. Fatality rates among pa-
tients with DSS can be 10 % or higher. Fluid resuscita-
tion is essential in DHF/DSS, but overly aggressive fluid
administration can exacerbate third space fluid losses,
which can lead to pulmonary edema and death when
plasma reabsorption occurs. Fatality rates among pa-
tients with DSS are typically around 2.5 %, or approxi-
mately 22,000 deaths per year [4, 5]. There are no
specific antiviral treatments for dengue.
Intravenous fluid therapy in DHF/DSS is guided by re-
peated physical examinations, frequent vital sign re-
assessment, serial hematocrits and imaging to assess for
intravascular fluid losses and extravascular fluid accumu-
lation (for example, pleural effusion, ascites). The latter
strategies are invasive (blood draws) and include expos-
ure to ionizing radiation (chest X-rays), both of which
are undesirable in children. Although these strategies
help to track volume status, compensatory mechanisms
limit their sensitivity until patients are at or near the
point of hemodynamic decompensation. Consequently,
the capability to measure the integrated response of
physiological mechanisms that reflect the sum total of
compensation to a relative blood volume deficit could
dramatically alter monitoring of patients with dengue
and multiple other conditions of hypovolemia. As such,
the purpose of the case studies on patients with DHF
reported in this paper was to determine if a novel com-
putational algorithm [6–8], originally developed for de-
tecting and monitoring blood loss in combat casualties,
could noninvasively indicate the clinical status of chil-
dren with dengue during the early stages of “shock”, and
track their fluid resuscitation status.
Case presentation
Patient selection
The cases of a 7-year-old Thai boy, another 7-year-old
Thai boy, and a 9-year-old Thai boy were selected to re-
port in this paper. The children presented to the Queen
Sirikit National Institute of Child Health (QSNICH),
Bangkok, Thailand with clinical suspicion of dengue.
None of the three boys met exclusion criteria that in-
cluded any known chronic condition (for example, liver
or renal disease, malignancy, or thalassemia). Informed
written consent from a parent or guardian was obtained.
This study was approved by the Institutional Review
Boards of the QSNICH, Thai Ministry of Public Health,
and US Army Surgeon General.
Study design
Our patients were classified and managed according to
the World Health Organization (WHO) 1997 guidelines
[2, 9, 10]. Intravenous fluid was initiated by the treating
physician at QSNICH when one or more of the follow-
ing were present: (1) signs suggestive of plasma leakage,
that is, rising hematocrit ≥10 % concurrent with
thrombocytopenia (platelet count ≤100,000/mm3) with
poor oral intake; (2) signs of poor peripheral perfusion,
including persistent tachycardia, delayed capillary refill
(more than 2 seconds), or narrow pulse pressure (≤20
mmHg); and/or (3) need for blood or colloid solution
transfusion determined by hematocrit and/or response
to fluids administered intravenously.
The following clinical parameters were assessed daily
during hospitalization: vital signs (oral temperature, re-
spiratory rate, pulse, and blood pressure collected manu-
ally every 3 hours); physical examination findings
(presence of ascites, liver enlargement, pleural effu-
sion(s), and hemorrhagic manifestations); tourniquet test
result; and complete blood count and serum albumin.
Oral intake of fluid and intake of fluid administered
intravenously, and urinary output were recorded and to-
taled every 24 hours. A daily ultrasound examination
was performed to assess for ascites, which was read as
either present or absent. A chest X-ray was obtained on
the day after defervescence (fever day +1) to assess for
the presence of pleural effusion, measured as pleural ef-
fusion index [9]. When a patient’s temperature was
below 38 °C for two consecutive 6-hour periods, then
hematocrit determination was conducted every 6 hours
by finger stick until stable. In order to track the progres-
sion of illness around defervescence and the response to
treatment, noninvasive blood pressure waveform data
were collected [9]. Patients were hospitalized until they
were afebrile, had stable vital signs, and were able to tol-
erate oral feedings. Additional blood for diagnostic test-
ing was collected on the day of enrollment and
approximately 5 to 9 days after discharge.
Clinical classification
Dengue cases were classified into DF or DHF grade I, II, III,
or IV, based on the 1997 WHO case definition [2, 9, 10].
The final case classification of DSS (DHF >III) was retro-
spectively determined by a physician who was a dengue ex-
pert; the dengue expert reviewed the medical records, but
did not participate in patient care.
Laboratory tests
DENV in plasma collected at study entry was detected
by a serotype-specific reverse transcriptase polymerase
chain reaction (RT-PCR) [11]. Cases were classified as
having primary or secondary DENV infection based on
the ratio of dengue-specific immunoglobulin G and im-
munoglobulin M. and by haemagglutination inhibition
assay on paired acute and convalescent samples as previ-
ously published [9]. The percent hematocrit change was
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calculated as: (highest hematocrit during hospitalization
– hematocrit at convalescence)/(hematocrit at convales-
cence × 100).
Noninvasive blood pressure waveform data collection
Continuous noninvasive photoplethysmographic (PPG)
waveforms were collected for approximately 15 minutes
per day using a Nexfin blood pressure monitor (Edwards
Lifesciences, Irvine, CA, USA). The sampling rate was
1000 Hz, exported at a rate of 200 Hz to a computer-
based data acquisition software package (WinDAQ;
Dataq Instruments, Akron, OH, USA).
The Compensatory Reserve Index (CRI) algorithm
The compensatory reserve represents a new paradigm
for measuring the sum total of all compensatory mecha-
nisms (for example, tachycardia, vasoconstriction,
breathing) that together contribute to “protect” against
inadequate tissue perfusion during blood loss and other
low circulating blood volume states [12]. The physiology
is based on the premise that the sum total of all com-
pensatory mechanisms involved in the control of cardiac
output (ejected wave) and peripheral vascular resistance
(reflected wave) are represented by the entirety of fea-
tures of the total arterial waveform. Thus, alterations in
specific waveform features represent changes in the re-
serve capacity to compensate for reduced circulating
blood volume. This concept is illustrated by the changes
in the arterial waveform between “normovolemia” and
central “hypovolemia” presented in Fig. 1. Feature ex-
traction and state-of-the-art machine-learning tech-
niques were used to develop a novel computational
algorithm that is capable of identifying and monitoring
patients during the compensatory phase of central blood
volume loss [6–8]. The algorithm was developed at the
University of Colorado using data obtained from experi-
ments conducted at the US Army Institute of Surgical
Research [6]. In these experiments, lower body negative
pressure (LBNP) was used to induce carefully controlled
reductions in central blood volume in 100 human partic-
ipants and validated on 101 different participants [8].
The way the Compensatory Reserve Index (CRI) algo-
rithm for measuring compensatory reserve works is by
processing 100 million data points per second in order
to evaluate subtle changes in hundreds of specific fea-
tures of the arterial waveform (outlined in red in Fig. 1).
The algorithm used for the current study analyzes how a
select group of noninvasive blood pressure waveform
features change over time, from normovolemia to de-
compensation. By monitoring multiple waveform fea-
tures and knowing how these features change with
central blood volume loss, the algorithm determines
how near or far an individual may be from the point of
decompensation. The algorithm outputs a single value in
a beat-to-beat fashion, termed the CRI [7]. Values be-
tween 1 and 0 indicate the compensatory reserve of the
patient, or the proportion of reserve capacity that re-
mains to compensate for central blood volume loss be-
fore the onset of decompensation at a CRI of zero.
Results
The clinical characteristics of each of our three patients
are presented in Table 1. All three children experienced
substantial plasma leakage as demonstrated by >25
pleural effusion index, ascites (by physical examination
and/or ultrasound) and >20 % hemoconcentration.
Fig. 1 Characteristic features of the arterial ejected and reflected waveforms in states of normovolemia (left panel) and central hypovolemia (right panel).
The red line indicates the integrated waveform that would be seen and recorded by an observer. Reproduced from Convertino et al. [12]
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Clinical evidence of shock included diminished pulse
pressure from day 1 to day 2, low systolic blood pressure
(Case 2 patient), and/or cold extremities (Table 1). All
three children received intravenous fluid during at least
the first 2 days of hospitalization and one received a
blood transfusion. All three had secondary DENV-2 in-
fections as documented by serology and RT-PCR, and
classified as DSS (DHF >III).
Noninvasive PPG waveform data from the three pa-
tients with DSS were de-identified and forwarded to
Flashback Technologies, Inc. (Boulder, CO, USA), where
the de-identified analog waveform signals were proc-
essed by the CRI algorithm. CRI results for these chil-
dren are shown in Fig. 2. All three children were
admitted with significantly low CRI values (≥0.20) on
the first and second study days. In all cases, CRI in-
creased on the third study day and the children showed
significant improvement towards normovolemia (that is,
CRI >0.75) by the end of the period of observation.
Discussion
In this case series study, a novel algorithm designed to
evaluate hemodynamic status based on noninvasive PPG
waveform data successfully detected reduced circulating
blood volume in three children hospitalized with DSS.
The CRI algorithm was originally developed from data
collected from experiments conducted on humans ran-
ging in age from 18 to 55 years for continuous, noninva-
sive, real-time monitoring of blood loss on the
battlefield [6–8]. Our findings in the present study using
the same algorithm demonstrate that this methodology
can be applied to children who present with DSS. The
etiology of shock in DSS is mainly related to plasma
leakage leading to reduced intravascular volume [2]. The
similarities of this process to hemorrhagic shock may
therefore have contributed to the success of the CRI al-
gorithm in this patient population. Based on the success-
ful translation of measuring the compensatory reserve in
young children (7 to 9 years of age), and the underlying
Table 1 Clinical characteristics of the study patients
Characteristic Case 1 patient Case 2 patient Case 3 patient
Age (years) 7 7 9
Gender M M M
Clinical diagnosis DHF grade III DHF grade III DHF grade III
RT-PCR DENV-2 DENV-2 DENV-2
Serologic response Secondary Secondary Secondary
Fever day at admission 0 –1 0
Percent hemoconcentration 28 44 39
Pleural effusion index 41 66 26
Clinical evidence of shock
Systolic BP <80 mmHg N Y N
Pulse pressure <20 mmHg Y Y Y
Cold extremities Y Y Y
Minimum systolic BP (mmHg)
Study day 1 97 74 97
Study day 2 96 87 93
Minimum pulse pressure (mmHg)
Study day 1 26 15 29
Study day 2 18 15 15
Fluid intake (ml/kg)
Study day 1 46 63 25
Study day 2 53 100 86
Study day 3 30 20 46
Study day 4 21 20 35
Transfusion (ml/kg) 4.9 (study day 1) None None
Other findings Ascites, upper GI bleeding Ascites Ascites, hemoconcentration, petechiae
Length of hospital stay, days 6 5 5
BP blood pressure, DENV dengue virus, DHF dengue hemorrhagic fever, GI gastrointestinal, M male, N no, RT-PCR reverse transcriptase polymerase chain reaction,
Y yes
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physiological concept of CRI, we hypothesize that the al-
gorithm may translate accurately to older patients des-
pite possible age-related differences in compensatory
responses. Separate clinical studies are currently being
conducted to test whether the algorithm will apply
equally well in other disease processes, such as sepsis, as
well as older patient populations.
All three patients had an abnormally low CRI at initial
presentation, consistent with the clinical evidence for
diagnosis of shock (Table 1). CRI values remained low for
several days despite fluid administration and, in one
patient, blood transfusion. CRI values gradually improved
and normalized by day 4 in one patient and by day 5 in
two patients (Fig. 2). In this regard, it is critical to avoid
hypervolemia in critically ill patients by targeting “ideal”
filling volume with the goal of minimizing or eliminating
the possibility of creating “third spacing” and interstitial
edema [13–15]. The progressive restoration of CRI during
resuscitative interventions in the present case studies sup-
ports the concept that the “individualized” assessment of
compensatory reserve may provide a patient-centric ap-
proach to goal-directed resuscitation and avoid clinical
complications of potential over-resuscitation.
The period of plasma leakage in DHF occurs within a
24 to 48 hour “critical phase” around the time of deferves-
cence [16]. The phenomenon of plasma leakage is evident
in the fluid volumes received by the three patients during
the first 3 days and further supported by serial ultrasound
evaluations. Intravenous fluid resuscitation in DSS is
guided by clinical assessment of peripheral perfusion and
serial hematocrit determinations. Overly aggressive fluid
administration is avoided to minimize the late complica-
tions of intravascular volume overload when the extravas-
cular fluid is resorbed [2]. The persistently low CRI values
that we observed in the first few days following deferves-
cence were likely due to some combination of plasma
leakage and the conservative approach to fluid therapy.
Data reported from controlled hemorrhage and blood re-
placement experiments conducted on human participants
support the findings of the present case studies that the
CRI can provide a more sensitive and specific indicator of
intravascular volume than the clinical assessments (that is,
standard vital signs) used to guide fluid therapy in DSS
[17–19]. A clinical trial comparing standard therapy to
CRI-directed fluid resuscitation will be required to
substantiate this hypothesis.
The three patients in our case series were managed ac-
cording to published guidelines for dengue case manage-
ment [2, 9, 10]; this represents the standard approach
used at our hospital. Intravenously administered fluid
therapy and blood transfusion (the latter given in case 1
only) are detailed in Table 1. The CRI algorithm was ap-
plied retrospectively to the analysis of PPG waveforms
that were collected in the course of hemodynamic moni-
toring. The results of this analysis, which are not cleared
by the US Food and Drug Administration (FDA) for
clinical use, were not provided to the clinicians nor used
to guide clinical care. As such, our report places the CRI
data in the context of routine clinical care to illustrate
the potential impact of the technology, with the caution
that the actual impact of using the CRI to guide patient
management would need to be validated in the context
of a clinical study done under rigorous standards. Case 1
Fig. 2 Compensatory Reserve Index values over successive days in
three children with dengue shock syndrome. Red (unstable), yellow
(moderately compromised), and green (adequate compensation)
bars indicate the 15 minute average Compensatory Reserve Index
for each study day; study day 1 represents the day of study
enrollment. CRI Compensatory Reserve Index, M male
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was discharged on day 6, and cases 2 and 3 were dis-
charged on day 5. All three patients were seen in clinic 4
days after discharge; all recovered fully with no sequelae.
The recognition that indicators of blood loss can be
linked to characteristic features of the photoplethysmo-
gram waveform is not new. However, there are distinct
advantages of the technological approach of PPG wave-
form analysis used in the CRI algorithm compared to
other technologies that employ arterial pulse contour
analysis for noninvasive estimates of cardiac output (for
example, PiCCO®, USCOM®). The measurement of
cardiac output alone fails to provide additional critical
information about other compensatory mechanisms (for
example, peripheral vascular control) for complete and
accurate assessment of patient status. Although proven
to be responsive to reductions in central blood volume
(that is, sensitivity), the primary limitation of these tech-
niques is that they are based on population averages
from clinical trials and fail to account for variation in an
individual patient’s ability to compensate and subse-
quently tolerate (that is, low specificity) severe reduc-
tions in circulating blood volume [12]. As such, the
relatively poor specificity produced by these population-
based algorithms fails to provide early prediction of
hemodynamic decompensation to progressive reduction
in central blood volume in those patients at greatest risk
for developing hemorrhagic shock. In contrast, measure-
ment of the compensatory reserve using the CRI algo-
rithm has now been validated in several studies of
experimentally controlled central hypovolemia [8, 19]
and clinical conditions of severe hemorrhage [20].
Through high-speed computing processes that combine
machine learning with feature extraction, we have devel-
oped an algorithm capable of integrating all of the physio-
logical compensatory mechanisms and the changes in
their status and features in response to compromised
circulating blood volume, which gives the CRI its unique
individual specific predictive capability to assess one’s
capacity to compensate. Unlike previous monitoring
algorithms that are based on average responses of clinical
populations, the CRI represents the first diagnostic tech-
nology for the assessment of compensatory status in an in-
dividual patient. Each patient’s compensatory reserve is
correctly estimated because the machine-learning capabil-
ity of the algorithm accounts for compromised circulating
blood volume. It “learns” and “normalizes” the totality of
compensatory mechanisms based on the individual’s arter-
ial waveform features, and thus provides “precision
medicine” that is patient centric for accurate diagnosis and
resuscitative treatment of the “individual” patient.
Conclusions
The present study provides preliminary evidence of the
value of the CRI algorithm in the management of clinical
conditions of central hypovolemia such as those associated
with dengue. Although the results should be interpreted
with caution given the small sample size and lack of com-
parative data from patients with milder forms of dengue
or other febrile illnesses, they were strikingly consistent in
all three patients. Balancing the limitations of the current
study are the significant potential advantages of this tech-
nology. The CRI algorithm provides a continuous, beat-to-
beat objective interpretation of PPG waveform data; the
interpretation does not require specialized expertise [6, 7].
The CRI algorithm does not require baseline or convales-
cent data; it can be acquired in real-time during any clin-
ical encounter [7, 8]. The machine-learning capability of
the CRI algorithm allows for identification of a specific pa-
tient, and thus provides individualized medicine. Lastly,
the CRI algorithm can interpret waveform data from non-
invasive monitoring devices that are relatively widely avail-
able, such as portable pulse oximeters, which could be
produced at low cost [7]. Thus, rapid translation of the
present findings to low-resource settings is highly feasible,
and would provide information that is not obvious to clini-
cians and other health care providers. Since delayed or
inappropriate medical care is a major factor in dengue-
related morbidity and mortality and other clinical condi-
tions of reduced central blood volume (for example,
hemorrhage), our data support the notion that the CRI al-
gorithm is a promising technology with the potential for
making a significant public health impact.
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